Wafaa El-Sadr, MD, MPH, MPA, global director of ICAP, was featured in a Nov 30 article by Global News Wire which announced that ICAP has been awarded a seven-year grant from the U.S. National Institutes of Health as part of the next funding cycle (2020-2027) for the HIV Prevention Trials Network (HPTN). This new funding cycle the HPTN will focus on four priority areas. Dr. El-Sadr says:

“We recognize that demonstrating the efficacy of a new agent is the first step in a critical research trajectory. Achieving impact requires reaching and engaging diverse populations and achieving high uptake and adherence with prevention methods, compelling the need for integration of biomedical with behavioral and structural interventions.”

Read the full article in Global News Wire

Read the latest ICAP updates on COVID-19 here

A major global health organization that has been improving public health in countries around the world for over 15 years, ICAP works to transform the health of populations through innovation, science, and global collaboration. Based at Columbia University in New York City, where it is part of the Mailman School of Public Health, ICAP has projects in more than 30 countries, working side-by-side with ministries of health and local partners to confront some of the world’s toughest health challenges. Through meaningful research, tailored technical assistance, effective training and education programs, and rigorous surveillance to measure and evaluate the impact of public health interventions, ICAP aims to realize a global vision of healthy people, empowered communities, and thriving societies. Online at icap.columbia.edu